Consolidation osimertinib for unresectable stage III epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer: redefining standard care.

ABSTRACT:

SUBMITTER: Wu F 

PROVIDER: S-EPMC11535829 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature